Molecular mechanism of tissue factor-mediated acceleration of factor VIIa activity.
The mechanism of the acceleration of the catalytic activity of factor VIIa (VIIa) in the presence of tissue factor (TF) was investigated. To explore the VIIa's site(s) that correlates with TF-mediated acceleration, zymogen VII, VIIa, and active site-modified VIIa were prepared, and dissociation constants (Kd) for their bindings to TF or soluble TF in solution were determined. We found that conversion of zymogen VII to VIIa led to an increase in affinity (DeltaDeltaG = 4.3-4.4 kJ/mol) for TFs. Dansyl-Glu-Gly-Arg chloromethyl ketone (DNS-EGRck) treatment of VIIa led to a further increase in the affinity (DeltaDeltaG = 7.3-12 kJ/mol). Neither removal of the Gla domain from VIIa nor truncation of the COOH-terminal membrane and cytoplasmic regions of TF affected the affinity enhanced after DNS-EGRck treatment of VIIa. Treatment of VIIa with (p-amidinophenyl)methanesulfonyl fluoride also enhanced its affinity for soluble TF, whereas treatment with 4-(2-aminoethyl)benzenesulfonyl fluoride, phenylmethylsulfonyl fluoride, or diisopropyl fluorophosphate had a slight effect on the affinity. On the other hand, DNS-EGRck and (p-amidinophenyl)methanesulfonyl fluoride treatments, but not diisopropyl fluorophosphate treatment, of VIIa led to protection of its alpha-amino group of Ile-153 from carbamylation. Protection of the alpha-amino group was consistent with formation of a critical salt bridge between Ile-153 and Asp-343 in the protease domain of VIIa. Therefore, TF may preferentially bind to the active conformational state of VIIa. When one assumes that free VIIa exists in equilibrium between minor active and dominant zymogen-like inactive conformational states, preferential binding of TF to the active state leads to a shift in equilibrium. We speculate that TF traps the active conformational state of VIIa and converts its zymogen-like state into an active state, thereby accelerating the VIIa activity.
Higashi
S
S
Department of Biology, Faculty of Science, Kyushu University 33, Fukuoka 812-81, Japan.
Matsumoto
N
N
Iwanaga
S
S
D000590:Amino Acid Chloromethyl Ketones / Q000737:chemistry; D000818:Animals; D002219:Carbamates / Q000737:chemistry; D002417:Cattle; D003593:Cytoplasm / Q000378:metabolism; D003619:Dansyl Compounds / Q000737:chemistry; D015942:Factor VIIa / Q000737:chemistry / Q000378:metabolism*; D010664:Phenylmethylsulfonyl Fluoride / Q000031:analogs & derivatives; D011485:Protein Binding; D013816:Thermodynamics; D013925:Thromboplastin / Q000378:metabolism*
D000590:Amino Acid Chloromethyl Ketones; D002219:Carbamates; D003619:Dansyl Compounds; D010664:Phenylmethylsulfonyl Fluoride; C030824:dansylglutamyl-glycyl-arginine chloromethyl ketone; D013925:Thromboplastin; D015942:Factor VIIa